Medtentia Helix Ring for Mitral Valve Repair Shows Promising Results
10/26/2012 7:47:55 AM
HELSINKI, Finland--(BUSINESS WIRE)--Medtentia International Ltd Oy today announced that the investigators at Helsinki University Hospital have successfully completed the recruitment of patients for the first phase of the clinical study evaluating the safety and performance of the Medtentia Helix Ring in adults undergoing mitral valve repair surgery. The preliminary results after a total of 36 patient months in the clinical study show consistent and sustained hemodynamic valve performance and support the unique advantages of the helix ring technology. All the safety and performance study objectives have so far been achieved.